| # | Drug | Count |
|---|---|---|
| 0 | ACETAMINOPHEN | 125 |
| 1 | ACETAMINOPHEN 500MG | 118 |
| 2 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 118 |
| 3 | PAIN RELIEVER | 118 |
| 4 | PREDNISONE | 95 |
| 5 | METOPROLOL TARTRATE | 83 |
| 6 | METOPROLOL | 82 |
| 7 | OXYCODONE | 75 |
| 8 | METOPROLOL TARTRATE INJECTION | 73 |
| 9 | IBUPROFEN | 68 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ETHIODIZED OIL | 9 | 0.0069 |
| 1 | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULES | 7 | 0.0039 |
| 2 | VASOPRESSIN | 11 | 0.0025 |
| 3 | GLUCAGON | 10 | 0.0024 |
| 4 | NOREPINEPHRINE BITARTRATE | 26 | 0.0018 |
| 5 | PERAMPANEL | 11 | 0.0014 |
| 6 | DOPAMINE HYDROCHLORIDE | 5 | 0.0013 |
| 7 | BLEOMYCIN SULFATE | 13 | 0.0013 |
| 8 | HYDROXOCOBALAMIN | 5 | 0.0012 |
| 9 | SEVOFLURANE | 9 | 0.0011 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 216 |
| 1 | Corticosteroid [EPC] | 162 |
| 2 | Opioid Agonist [EPC] | 99 |
| 3 | Dihydropyridine Calcium Channel Blocker [EPC] | 68 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 64 |
| 5 | Alkylating Drug [EPC] | 61 |
| 6 | Benzodiazepine [EPC] | 58 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 58 |
| 8 | Calcium Channel Blocker [EPC] | 54 |
| 9 | Atypical Antipsychotic [EPC] | 39 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tricyclic Antidepressant [EPC] | 2 | 0.0042 |
| 1 | Antihypoglycemic Agent [EPC] | 10 | 0.0023 |
| 2 | Benzodiazepine Antagonist [EPC] | 2 | 0.0023 |
| 3 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 11 | 0.0014 |
| 4 | Hematopoietic Stem Cell Mobilizer [EPC] | 2 | 0.0013 |
| 5 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 1 | 0.0009 |
| 6 | Actinomycin [EPC] | 2 | 0.0009 |
| 7 | Tetracycline-class Antibacterial [EPC] | 7 | 0.0009 |
| 8 | Lipid-based Polyene Antifungal [EPC] | 10 | 0.0008 |
| 9 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 17 | 0.0008 |